Recent

% | $
Quotes you view appear here for quick access.

VMware, Inc. Message Board

stocker4949 349 posts  |  Last Activity: 15 hours ago Member since: Aug 31, 2006
SortNewest  |  Oldest  |  Highest Rated Expand all messages
  • Rite Aid Can Be Trusted To Generate Strong Financial Numbers Going Forward
    Jun. 26, 2015 3:19 AM ET | 9 comments | About: Rite Aid Corporation (RAD)

    Disclosure: I/we have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours. (More...)
    Summary

    Continuously improving its store base, enhanced pharmacy services and an improved loyalty program portends well for company.
    Growth investments will keep profitability and margins pressurized in the near term.
    RAD's growth investments will serve as an important means of growing long-term revenue, profitability and cash flow base.

    I reiterate my bullish stance on Rite Aid (NYSE:RAD); the company's strategic growth activities, focused on having an expanded pharmacy store network and extended range of clinical services, will positively affect its position in the industry. Owing to RAD's sustained focus on gaining market share through its numerous growth generating initiatives, such as store network expansion, remodeling of existing stores, expansion through acquisitions and ongoing improvements in loyalty program offers, will improve its image as a health and wellness service provider and will keep the company on a revenue, earnings and cash flow growth track in the years ahead.
    Strong Strategic Growth Drivers

    In the past few years, the rapid increase in the aging U.S. population and initiation of healthcare services like the Affordable Care Act (ACA) have opened new avenues of growth for pharmacy retailers. In their attempts to capitalize on the growth potential of the U.S. Pharmacy Retail industry, almost all pharmacy retailers have accelerated their growth investments, due to which, sales from privately held U.S. pharmacy retailers grew by 6.3% in 2014, up from sales growth of 3.1% in 2013. As far as RAD is concerned, the company has also accelerated its growth investments. Its 1QFY16 results indicate that the company is progressing well with its long-term gr

  • Strong buy now.

    Sentiment: Strong Buy

  • Short term to $150. Long term to be over $300.

    Sentiment: Strong Buy

  • Desperate Parents Of Autistic Children Trying Cannabis Despite Lack Of Studies
    Comment Now Follow Comments

    Parents of severely autistic children are turning to medical marijuana for relief. After seeing the results that epileptic children experienced, these desperate parents are beginning to wonder if it will work for them too. There are very few studies linking cannabinoids as a treatment for autism, but that isn’t holding these parents back. Most figure they don’t have anything to lose.

    Autism is a neurodevelopmental disorder known for its ability to impair communication and social interaction. Some children are able to function well with various treatments, while others suffer with the inability to speak and self-harming behaviors. According to the Center for Disease Control and Prevention, 1.5% of the children in the U.S. are diagnosed with autism as of 2014, so this is a huge patient population.
    ADVERTISING

    They are using CBD or cannabidiol, which can be derived from marijuana and hemp plants. Marijuana has higher levels of THC than hemp, which causes the “high” effect, while CBD contains the medical properties. Hemp has more CBD than marijuana, but less of the medicinal compound within CBD to have an effect. Marijuana plants can be bred to have higher levels of CBD and then those flowers are used to create CBD oil. It can also be extracted from hemp plants, which contains a large amount of CBD, but with less strength of the medicinal cannabidiol compound, according to the Hemp Industries Association.

    WASHINGTON, DC – APRIL 22: Liza Smith (L) of White Stone, Virginia, comforts her14-year-old Haley Smith (2nd L) who suffers from a severe form of epilepsy called Dravet Syndrome, as she listens during a news conference at the National Press Club April 22, 2015 in Washington, DC. U.S. Rep. Scott Perry (R-PA) discussed during the news conference his proposed Charlotte’s Web Medical Access Act to legalize therapeutic hemp and cannabidiol (CBD) by excluding them

    Sentiment: Strong Buy

  • Don't be a blind sheep following stupid analyst that tries to talk it down. Let the math does its own work. Numbers speak louder than words.

  • The stock can easily goes up $100 dollars in one day when that happens.

    Sentiment: Strong Buy

  • Patience is the key.

    Sentiment: Strong Buy

  • Investing stocks
    Rite Aid Is Winning With These Smart Moves

    Michael Douglass / Motley Fool

    11:34 AM ET
    A Rite Aid Corp. Store Ahead Of Earnings Figures
    Bloomberg via Getty Images Pedestrians walk past a Rite Aid Corp. store in New York, U.S., on Monday, April 6, 2015.
    The healthcare chain is finally firing on all cylinders.
    CVS announced it had completed removing cigarettes and other tobacco products for sale from its store a month before its October 1st deadline by "putting out" a 50-foot tall cigarette in Bryant Park on September 3, 2014 in New York City.
    More
    Here’s What Happened After CVS Stopped Selling Cigarettes
    Here’s How Much We Spent on Prescription Drugs Last Year
    Healthy Convenience Store Foods for Your Next Road Trip

    Rite Aid is one of the most fascinating turnaround stories in healthcare. Buried under a pile of debt for years and abandoned by the market, management is pushing the company through some transformative growth opportunities by aligning the company increasingly with a changing healthcare landscape.

    But while the back-end pharmacy work is important — 68.8% of the last fiscal year’s revenue, in fact — there’s also some good old-fashioned spadework management is doing to get front-store revenues churning faster as well. Here are three big moves management is making that you need to keep an eye on.

    The easy layup
    Rite Aid has been redesigning its stores around a new Wellness model for years. The stores have organic and gluten-free foods available, as well as wellness reading materials, nutritional supplements, and a host of other offerings built around enhancing wellness. And while that may all sound rather ho-hum, the results have been impressive: Rite Aid recently reported that Wellness stores remodeled in the last two years showed a 3.32 percentage point bump in front-end comps and a 1.95 percentage point bump in script growth compared to non-Wellness stores.

    With a proven, working model like that, it’s no wonder Rite Aid is swiftl

    Sentiment: Strong Buy

  • The oil is cheap and you don't see the drop of ticket sales and price.

    Sentiment: Strong Buy

  • stocker4949 stocker4949 Jul 24, 2015 11:50 AM Flag

    Morgan Stanley almost went bankrupt in 2009 and now owns by Japanese. They must have been shorted HTZ. They shall be investigated by SEC. Carl Icahn owns 2.63 million shares at $21.36 which is counted 10% of the entire HTZ stock. HTZ at this level is a strong buy.

  • I think MNST is a good buy at this level.

    Sentiment: Buy

  • Buckle up.

  • Happy days are here again.

    Sentiment: Strong Buy

  • 45 million dollars of the business is a great start.

    Sentiment: Strong Buy

  • stocker4949 stocker4949 Jun 29, 2015 10:38 AM Flag

    In fact, this is a great stock to add more to its weakness.

  • stocker4949 stocker4949 Jul 7, 2015 3:20 PM Flag

    bump, bump.

    Sentiment: Strong Buy

  • Rite Aid (RAD) Stock Still Gaining After Strong June Sales
    By U-Jin Lee
    Follow
    | 07/06/15 - 11:16 AM EDT
    Get TheStreet Quant Ratings' exclusive 5-page report for (RAD) - FREE.
    0

    NEW YORK (TheStreet) -- Rite Aid (RAD - Get Report) stock is advancing 0.04% to $8.40 in Monday's morning trading session after the company announced strong sales results for June.

    Same store sales rose 2.4% in June over the same period last year, as growth was led by the pharmacy section, the company said last week.

    Specifically, at comparable locations pharmacy same store sales, which included a negative impact of 2.26 percentage points related to recent generic drug introductions, improved by 3.4% in June, the company noted.

    Additionally, prescription count increased 0.2% over the same period last year.

    Regarding total drugstores sales, the company reported $2.04 billion, which is up 2.2% from $1.995 billion in the same period the previous year.

    Rite Aid operates a chain of retail drugstores in the U.S., selling prescription drugs, and a range of other merchandise, including medications, health and beauty aids.

    Separately, TheStreet Ratings team rates RITE AID CORP as a Hold with a ratings score of C. TheStreet Ratings Team has this to say about their recommendation:

    "We rate RITE AID CORP (RAD) a HOLD. The primary factors that have impacted our rating are mixed, some indicating strength, some showing weaknesses, with little evidence to justify the expectation of either a positive or negative performance for this stock relative to most other stocks. The company's strengths can be seen in multiple areas, such as its notable return on equity, revenue growth and good cash flow from operations. However, as a counter to these strengths, we also find weaknesses including unimpressive growth in net income, generally higher debt management risk and poor profit margins."

    Highlights from the analysis by TheStreet Ratings Team goes as follows:

    Compared to other companies in the Foo

    Sentiment: Strong Buy

  • Reply to

    Walgreens makes bid for RAD over the weekend

    by takithom Jul 10, 2015 12:01 PM
    stocker4949 stocker4949 Jul 10, 2015 1:27 PM Flag

    I think it will be a good business decision for WalMart to buy RiteAid.

    Sentiment: Strong Buy

VMW
88.51+1.28(+1.47%)Jul 30 4:02 PMEDT